99 related articles for article (PubMed ID: 17970071)
21. Immunodetection of GLUT1, p63 and phospho-histone H1 in invasive head and neck squamous carcinoma: correlation of immunohistochemical staining patterns with keratinization.
Burstein DE; Nagi C; Kohtz DS; Lee L; Wang B
Histopathology; 2006 May; 48(6):717-22. PubMed ID: 16681688
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical detection of X-linked inhibitor of apoptosis in head and neck squamous cell carcinoma.
Nagi C; Xiao GQ; Li G; Genden E; Burstein DE
Ann Diagn Pathol; 2007 Dec; 11(6):402-6. PubMed ID: 18022123
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity of primary site biopsies in head and neck squamous cell carcinoma.
Moertel S; Ackermann H; Baghi M; Eckardt A; Wagenblast J; Stöver T; Hambek M
Anticancer Res; 2011 Feb; 31(2):665-9. PubMed ID: 21378353
[TBL] [Abstract][Full Text] [Related]
24. Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers.
Boldrup L; Coates PJ; Hedberg Y; Sjöström B; Dahlqvist A; Nylander K
Int J Oncol; 2005 Dec; 27(6):1661-7. PubMed ID: 16273222
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y
Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
[TBL] [Abstract][Full Text] [Related]
26. Retinoic acid receptor beta induces terminal differentiation of squamous cell carcinoma lines in the absence of cyclin-dependent kinase inhibitor expression.
Crowe DL
Cancer Res; 1998 Jan; 58(1):142-8. PubMed ID: 9426070
[TBL] [Abstract][Full Text] [Related]
27. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
Muro-Cacho CA; Rosario-Ortiz K; Livingston S; Muñoz-Antonia T
Clin Cancer Res; 2001 Jun; 7(6):1618-26. PubMed ID: 11410498
[TBL] [Abstract][Full Text] [Related]
28. Cytokeratins 6 and 16 are frequently expressed in head and neck squamous cell carcinoma cell lines and fresh biopsies.
Sesterhenn AM; Mandic R; Dünne AA; Werner JA
Anticancer Res; 2005; 25(4):2675-80. PubMed ID: 16080511
[TBL] [Abstract][Full Text] [Related]
29. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
[TBL] [Abstract][Full Text] [Related]
30. Expression of MAGE A 1-6 mRNA in sputa of head and neck cancer patients--a preliminary report.
Lee KD; Lee HH; Joo HB; Lee HS; Yu TH; Chang HK; Jeon CH; Park JW
Anticancer Res; 2006; 26(2B):1513-8. PubMed ID: 16619566
[TBL] [Abstract][Full Text] [Related]
31. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
32. Proliferation of epithelia of noninvolved mucosa in patients with head and neck cancer.
Kotelnikov VM; Coon JS; Taylor S; Hutchinson J; Panje W; Caldareill DD; LaFollette S; Preisler HD
Head Neck; 1996; 18(6):522-8. PubMed ID: 8902565
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of GLUT-1 immunoreactivity to distinguish benign from malignant cystic squamous lesions of the head and neck in fine-needle aspiration biopsy material.
Weiner MF; Miranda RN; Bardales RH; Mukunyadzi P; Baker SJ; Korourian S; De Las Casas LE
Diagn Cytopathol; 2004 Nov; 31(5):294-9. PubMed ID: 15468132
[TBL] [Abstract][Full Text] [Related]
34. Expression of transforming growth factor beta type II receptors in head and neck squamous cell carcinoma.
Muro-Cacho CA; Anderson M; Cordero J; Muñoz-Antonia T
Clin Cancer Res; 1999 Jun; 5(6):1243-8. PubMed ID: 10389906
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.
Sauter ER; Nesbit M; Watson JC; Klein-Szanto A; Litwin S; Herlyn M
Clin Cancer Res; 1999 Apr; 5(4):775-82. PubMed ID: 10213212
[TBL] [Abstract][Full Text] [Related]
36. [Expression of retinoic acid receptors in head and neck squamous cell carcinomas and their possible implication for chemoprevention].
Issing WJ
Laryngorhinootologie; 2001 Sep; 80(9):530-4. PubMed ID: 11555786
[TBL] [Abstract][Full Text] [Related]
37. Keratin 8 expression in head and neck epithelia.
Matthias C; Mack B; Berghaus A; Gires O
BMC Cancer; 2008 Sep; 8():267. PubMed ID: 18803884
[TBL] [Abstract][Full Text] [Related]
38. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
39. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
40. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
Masuda M; Suzui M; Yasumatu R; Nakashima T; Kuratomi Y; Azuma K; Tomita K; Komiyama S; Weinstein IB
Cancer Res; 2002 Jun; 62(12):3351-5. PubMed ID: 12067972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
